Chevy Chase Trust’s AbbVie ABBV Stock Holding History

Chevy Chase Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$197M	Sell	904,397 -25,492	-3%	-$5.65M	0.57%	22
2025 Q4	$212M	Sell	929,889 -673	-0.1%	-$153K	0.57%	21
2025 Q3	$215M	Sell	930,562 -31,706	-3%	-$6.46M	0.59%	23
2025 Q2	$179M	Buy	962,268 +4,990	+0.5%	+$927K	0.52%	28
2025 Q1	$201M	Sell	957,278 -4,001	-0.4%	-$778K	0.64%	24
2024 Q4	$171M	Sell	961,279 -20,317	-2%	-$3.74M	0.52%	29
2024 Q3	$194M	Sell	981,596 -15,603	-2%	-$2.91M	0.59%	28
2024 Q2	$171M	Sell	997,199 -14,283	-1%	-$2.37M	0.55%	30
2024 Q1	$184M	Sell	1,011,482 -8,884	-0.9%	-$1.53M	0.6%	30
2023 Q4	$158M	Sell	1,020,366 -12,949	-1%	-$1.89M	0.57%	29
2023 Q3	$154M	Sell	1,033,315 -24,230	-2%	-$3.56M	0.61%	28
2023 Q2	$142M	Sell	1,057,545 -14,580	-1%	-$2.14M	0.53%	34
2023 Q1	$171M	Buy	1,072,125 +10,311	+1%	+$1.58M	0.68%	28
2022 Q4	$172M	Sell	1,061,814 -61,737	-5%	-$9.47M	0.73%	26
2022 Q3	$151M	Buy	1,123,551 +12,408	+1%	+$1.78M	0.64%	31
2022 Q2	$170M	Buy	1,111,143 +4,269	+0.4%	+$652K	0.7%	26
2022 Q1	$179M	Buy	1,106,874 +1,155	+0.1%	+$168K	0.62%	28
2021 Q4	$150M	Sell	1,105,719 -22,219	-2%	-$2.62M	0.48%	40
2021 Q3	$122M	Sell	1,127,938 -42,718	-4%	-$4.88M	0.42%	52
2021 Q2	$132M	Sell	1,170,656 -61,383	-5%	-$6.91M	0.45%	46
2021 Q1	$133M	Sell	1,232,039 -67,632	-5%	-$7.23M	0.48%	41
2020 Q4	$139M	Sell	1,299,671 -59,976	-4%	-$5.76M	0.5%	41
2020 Q3	$119M	Sell	1,359,647 -136,895	-9%	-$12.9M	0.47%	46
2020 Q2	$147M	Buy	1,496,542 +166,521	+13%	+$14.7M	0.6%	34
2020 Q1	$101M	Buy	1,330,021 +17,736	+1%	+$1.51M	0.47%	49
2019 Q4	$116M	Sell	1,312,285 -3,588	-0.3%	-$298K	0.44%	52
2019 Q3	$99.6M	Sell	1,315,873 -4,097	-0.3%	-$281K	0.41%	58
2019 Q2	$96M	Sell	1,319,970 -2,352	-0.2%	-$185K	0.4%	63
2019 Q1	$105M	Sell	1,322,322 -9,789	-0.7%	-$801K	0.43%	53
2018 Q4	$123M	Sell	1,332,111 -39,195	-3%	-$3.45M	0.6%	36
2018 Q3	$130M	Sell	1,371,306 -32,271	-2%	-$3.06M	0.54%	39
2018 Q2	$130M	Sell	1,403,577 -69,543	-5%	-$6.79M	0.56%	35
2018 Q1	$139M	Sell	1,473,120 -28,773	-2%	-$3.16M	0.62%	34
2017 Q4	$145M	Sell	1,501,893 -11,675	-0.8%	-$1.1M	0.63%	32
2017 Q3	$134M	Buy	1,513,568 +21,770	+1%	+$1.66M	0.61%	35
2017 Q2	$108M	Sell	1,491,798 -3,214	-0.2%	-$216K	0.52%	42
2017 Q1	$97.4M	Buy	1,495,012 +11,789	+0.8%	+$741K	0.48%	45
2016 Q4	$92.9M	Buy	1,483,223 +9,122	+0.6%	+$557K	0.49%	45
2016 Q3	$93M	Sell	1,474,101 -22,783	-2%	-$1.47M	0.51%	44
2016 Q2	$92.7M	Buy	1,496,884 +7,149	+0.5%	+$436K	0.52%	45
2016 Q1	$85.1M	Buy	1,489,735 +10,509	+0.7%	+$586K	0.49%	49
2015 Q4	$87.6M	Sell	1,479,226 -14,153	-0.9%	-$815K	0.51%	45
2015 Q3	$81.3M	Sell	1,493,379 -8,374	-0.6%	-$545K	0.51%	46
2015 Q2	$101M	Buy	1,501,753 +111,890	+8%	+$7.3M	0.6%	37
2015 Q1	$81.4M	Buy	1,389,863 +44,409	+3%	+$2.68M	0.49%	47
2014 Q4	$88M	Sell	1,345,454 -11,278	-0.8%	-$711K	0.55%	40
2014 Q3	$78.4M	Buy	1,356,732 +92,068	+7%	+$5.11M	0.51%	41
2014 Q2	$71.4M	Sell	1,264,664 -24,272	-2%	-$1.27M	0.5%	44
2014 Q1	$66.3M	Buy	1,288,936 +6,717	+0.5%	+$339K	0.47%	43
2013 Q4	$67.7M	Buy	1,282,219 +18,023	+1%	+$886K	0.49%	43
2013 Q3	$56.5M	Buy	1,264,196 +30,814	+2%	+$1.37M	0.46%	45
2013 Q2	$51M	Buy	+1,233,382	New	+$53.9M	0.45%	47

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chevy Chase Trust's ABBV Position: Q1 2026 in Review

Chevy Chase Trust reduced its AbbVie (ABBV) stake by 2.7% in Q1 2026, selling an estimated $5.65M and leaving 904,397 shares worth $197M. The position accounts for 0.57% of the portfolio, ranked #22.

Chevy Chase Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $215M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Chevy Chase Trust held 904,397 shares of AbbVie worth $197M as of Q1 2026.
Chevy Chase Trust sold 25,492 AbbVie shares in Q1 2026, an estimated $5.65M.
AbbVie made up 0.57% of Chevy Chase Trust's portfolio in Q1 2026, its #22 holding.
Chevy Chase Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Chevy Chase Trust's AbbVie position peaked at $215M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.